Kezar Life Sciences, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| ADVISOR GROUP HOLDINGS, INC. | 02/07/2025 | 3,686 | $2,838 | -21.00% | 0.01% |
| JPMORGAN CHASE & CO | 02/12/2025 | 0 | $0 | -100.00% | 0.00% |
| WELLS FARGO & COMPANY/MN | 02/13/2025 | 0 | $0 | -100.00% | 0.00% |
| STATE STREET CORP | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| VANGUARD GROUP INC | 02/11/2025 | 0 | $0 | -100.00% | 0.00% |
| FMR LLC | 02/13/2025 | 0 | $0 | -100.00% | 0.00% |
| CITIGROUP INC | 02/12/2025 | 0 | $0 | -100.00% | 0.00% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 0 | $0 | -100.00% | 0.00% |
| GOLDMAN SACHS GROUP INC | 02/11/2025 | 0 | $0 | -100.00% | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 02/11/2025 | 0 | $0 | -100.00% | 0.00% |
| DEUTSCHE BANK AG\ | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 0 | $0 | -100.00% | 0.00% |
| ORBIMED ADVISORS LLC | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| FEDERATED HERMES, INC. | 02/13/2025 | 0 | $0 | -100.00% | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 02/10/2025 | 0 | $0 | -100.00% | 0.00% |
| RBF CAPITAL, LLC | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 0 | $0 | -100.00% | 0.00% |
| TANG CAPITAL MANAGEMENT LLC | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| CIBC PRIVATE WEALTH GROUP, LLC | 02/12/2025 | 0 | $0 | -100.00% | 0.00% |
| AVANTAX ADVISORY SERVICES, INC. | 02/10/2025 | 0 | $0 | -100.00% | 0.00% |
| AMUNDI | 02/07/2025 | 0 | $0 | -100.00% | 0.00% |
| MARQUETTE ASSET MANAGEMENT, LLC | 01/14/2025 | 0 | $0 | -100.00% | 0.00% |
| STONEPINE CAPITAL MANAGEMENT, LLC | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| HRT FINANCIAL LP | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| TWO SIGMA ADVISERS, LP | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| SIMPLEX TRADING, LLC | 02/11/2025 | 0 | $0 | -100.00% | 0.00% |
| SPHERA FUNDS MANAGEMENT LTD. | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| ACUITAS INVESTMENTS, LLC | 01/31/2025 | 0 | $0 | -100.00% | 0.00% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 02/13/2025 | 0 | $0 | -100.00% | 0.00% |
| GROUND SWELL CAPITAL, LLC | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| JANE STREET GROUP, LLC | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| UBS GROUP AG | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| ENGINEERS GATE MANAGER LP | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| SQUAREPOINT OPS LLC | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| RETIREMENT CAPITAL STRATEGIES | 02/07/2025 | 0 | $0 | -100.00% | 0.00% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| GLOBAL RETIREMENT PARTNERS, LLC | 01/31/2025 | 0 | $0 | -100.00% | 0.00% |
| RVW WEALTH, LLC | 01/23/2025 | 0 | $0 | -100.00% | 0.00% |
| AFFINITY ASSET ADVISORS, LLC | 02/13/2025 | 0 | $0 | -100.00% | 0.00% |
| IKARIAN CAPITAL, LLC | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| AVIDITY PARTNERS MANAGEMENT LP | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| XTX TOPCO LTD | 02/13/2025 | 0 | $0 | -100.00% | 0.00% |
| QIMING U.S. VENTURES MANAGEMENT, LLC | 01/28/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Kezar Life Sciences, Inc. institutional Ownership - FAQ's
During the previous two years, 71 institutional investors and hedge funds held shares of Kezar Life Sciences, Inc.. The most heavily invested institutionals were:
ADVISOR GROUP HOLDINGS, INC.: 3,686
VANGUARD GROUP INC: 0
SUSQUEHANNA INTERNATIONAL GROUP, LLP: 0
GOLDMAN SACHS GROUP INC: 0
Squarepoint Ops LLC: 0
FEDERATED HERMES, INC.: 0
0.01% of Kezar Life Sciences, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 3.88 M shares in the last 24 months. This purchase volume represents approximately $25.78 M in transactions.